Guidance Documents - Drug Manufacturers and Distributors
Guidance Documents - Drug Manufacturers and Distributors
Prescription drug distributors must operate in compliance with rules found in 25 Texas Administrative Code (TAC), Sections 229.419 - 229.430 - Licensing of Wholesale Distributors of Prescription Drugs; Including Good Manufacturing Practices. Section 229.420 of these rules adopts by reference certain federal laws and regulations applicable to prescription drug distributors, including the requirements in Title 21, Code of Federal Regulations (CFR), Part 205, Guidelines for State Licensing of Wholesale Prescription Drug Distributors.
Compressed Gases
-
Batch Record for Medical Liquid Oxygen (Home Units Filled Curbside) (DOC, 46 KB)
-
Batch Production Record for Compressed Medical Gas (CMG) (PDF, 76 KB)
-
Example Procedures for Welding Supply & DME Firms (DOC, 26 KB)
Policies & Procedure Requirements
Prescription drug distributors are required to establish, maintain and adhere to all written policies and procedures required in 21 CFR, Part 205 - Section 205.50(g). Among these are policies and procedures for the receipt, security, storage, recall, inventory (including correcting all errors and inaccuracies), and distribution of prescription drugs (e.g., stock rotation; identifying, recording, and reporting losses or thefts; and disaster preparedness).
According to 21 CFR, Part 205 – Section 205.50(c), “All prescription drugs shall be stored at appropriate temperatures and under appropriate conditions in accordance with requirements, if any, in the labeling of such drugs, or with requirements in the current edition of an official compendium, such as the United States Pharmacopeia/National Formulary (USP/NF).” Therefore, you should check the drug labeling for any temperature requirements and, according to Section 205.50(c)(2), if there are requirements, “Appropriate manual, electromechanical, or electric temperature and humidity recording equipment, devices, and/or logs shall be utilized to document proper storage of prescription drugs.”
Prescription Drug Guidance
Health and Safety Code Chapter 483, Texas Dangerous Drug Act, designates the following people as authorized to possess a dangerous drug:
-
Pharmacies licensed by the Texas State Board of Pharmacy
-
Practitioners (for example: medical doctors, dentists)
-
Persons who obtain a dangerous drug for lawful research, teaching, or testing, but not for resale
-
Hospitals that obtain a dangerous drug for lawful administration by a practitioner
-
Officers or employees of the federal, state or local government
-
A manufacturer or wholesaler licensed by the Department of State Health Services under Chapter 431 (Texas Food, Drug, and Cosmetic Act)
-
Carriers or warehousemen
-
Home and community support services agencies licensed under and acting in accordance with Chapter 142, Health and Safety Code
-
Documented midwives, (Oxygen U.S.P. only) for use in deliveries; and
-
People with a prescription drug, dispensed by a pharmacist, pursuant to a valid prescription
According to 21 CFR, Part 205 – Section 205.50(a)(3), “All facilities at which prescription drugs are stored, warehoused, handled, held, offered, marketed, or displayed, shall have a quarantine area for storage of prescription drugs that are outdated, damaged, deteriorated, misbranded, or adulterated, or that are in immediate or sealed, secondary containers that have been opened.”
If your firm distributes medical devices in addition to prescription drugs, you need a license to distribute the devices. If the prescription drugs you distribute are restricted to medical gases only, you might be eligible for a Multiple Products License. Visit our Drug Manufacturers and Distributors Licensing Requirements webpage for more information on Multiple Products Licenses. If you distribute prescription drugs other than medical gases and are interested in becoming licensed as a device distributor, visit our Medical Device Manufacturers and Distributors Licensing Requirements webpage.
Policies & Procedure Additional Resources
For more Industry guidance and requirements on prescription drugs, visit Controlled Substances and Abusable Synthetic Substances.